Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
Altun
B
B
Erdem
Y
Y
Haznedaroğlu
I
I
Gürsoy
M
M
Yasavul
U
U
Turgan
C
C
Cağlar
S
S
Kirazli
S
S
D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015375:Receptors, Interleukin-2 / Q000187:drug effects / Q000378:metabolism*; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis
D015375:Receptors, Interleukin-2; D011994:Recombinant Proteins; D004921:Erythropoietin